By MATTHEW PERRONE - AP Health Writer
WASHINGTON (AP) — Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from…
By MATTHEW PERRONE - AP Health Writer
WASHINGTON (AP) — U.S. officials have approved the first pharmaceutical-grade version of the so-called fecal transplant procedures that doctors have increasingly…
New York, USA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Pharmaceutical Contract Manufacturing Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Pharmaceutical Contract Manufacturing Market…
By TOM MURPHY - AP Health Writer
Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug developer continues to recover from its failed launch of the…
AP
BERLIN (AP) — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, reported that its earnings in the third quarter were close to half what they were a year earlier, but the…
By EDNA TARIGAN - Associated Press
JAKARTA, Indonesia (AP) — Indonesian authorities have revoked the licenses of two pharmaceutical companies to produce syrup-type medicines following the deaths of 159…
By TOM MURPHY - AP Health Writer
Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots, but the drugmaker says it expects many people will…
By NINIEK KARMINI - Associated Press
JAKARTA, Indonesia (AP) — Indonesia's leader launched the country’s first home-grown COVID-19 shot Thursday to help reduce the world’s fourth most populous nation’s…
BOSTON (AP) — Biogen has agreed to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said.The…